Core Insights - The Ministry of Finance announced the ranking of the trading volume of 2025 book-entry government bonds, with Ping An Bank, CITIC Securities, and Orient Securities taking the top three spots [1] Group 1: Bank Members - Among the bank members of the 2025 book-entry government bond underwriting syndicate, Ping An Bank, Shanghai Pudong Development Bank, and Bank of Communications ranked as the top three [1] Group 2: Non-Bank Members - In the non-bank category, CITIC Securities, Orient Securities, and Huatai Securities were the top three firms based on trading volume [1] Group 3: Counter Transactions - For bank counter transaction volumes, Agricultural Bank of China, Shanghai Pudong Development Bank, and Bank of China ranked as the top three [1]

21世纪经济报道记者 孙永乐 正值A股年报预告披露期，一批上市券商密集"交卷"报喜。 1月28日下午，长城证券（002939.SZ）发布业绩预告，公司预计2025年1-12月业绩大幅上升，归母净利润为22.91亿至24.49亿元，净利润同比增长45.00%至 55.00%，预计基本每股收益为0.57至0.61元。 就在前一晚，国泰海通（601211.SH）、申万宏源（000166.SZ）、东方证券（600958.SH）、招商证券（600999.SH）、华西证券（002926.SZ）、红塔证券 （601236.SH），6家券商同步发布了2025年业绩预告或快报，全年归母净利润分别同比增长111%—115%、74.64%—93.83%、67.80%、18.43%、74.46%— 126.66%、59.05%。 同花顺iFinD数据显示，截至1月28日18时，A股已有13家上市券商披露2025年度业绩预告或快报，业绩集体实现高增，3家净利润同比增长10%—50%，7家 净利润同比增长50%—100%，3家净利润同比增长超过100%。 | | | | A股券商2025年业绩预告/快报一览 | | | | | --- ...

同花顺iFinD数据显示，截至1月28日18时，A股已有13家上市券商披露2025年度业绩预告或快报，业绩 集体实现高增，3家净利润同比增长10%—50%，7家净利润同比增长50%—100%，3家净利润同比增长 超过100%。 （文章来源：21世纪经济报道） 1月28日下午，长城证券（002939.SZ）发布全年业绩预告，公司预计2025年1-12月业绩大幅上升，归母 净利润为22.91亿至24.49亿，净利润同比增长45.00%至55.00%，预计基本每股收益为0.57至0.61元。 就在前一晚，国泰海通（601211.SH）、申万宏源（000166.SZ）、东方证券（600958.SH）、招商证券 （600999.SH）、华西证券（002926.SZ）、红塔证券（601236.SH），这6家券商同步发布了2025年业绩 预告或快报，全年归母净利润分别同比增长111%—115%、74.64%—93.83%、67.80%、18.43%、74.46% —126.66%、59.05%。 ...

Group 1 - The company Zhou Dasheng announced that it will participate in an investor research meeting on January 28, 2026, with representatives from Dongfang Securities present to answer investor questions [1] - The automotive industry is experiencing a significant shift with the introduction of semi-solid state batteries, which are expected to be featured in multiple new vehicle models this year [1] - Major manufacturers are preparing for advancements in power battery technology, marking this year as a pivotal moment for innovation in the sector [1]

Performance Highlights - State Grid Yingda (600517.SH) expects a net profit of 2.3 billion to 2.75 billion CNY, a year-on-year increase of 46.10% to 74.69%[3] - Zhongjin Gold (600489.SH) anticipates a net profit of 4.8 billion to 5.4 billion CNY, reflecting a growth of 41.76% to 59.48%[4] - Shenzhen South Circuit (002916.SZ) projects a net profit of 3.154 billion to 3.342 billion CNY, with an increase of 68% to 78%[5] - Electric Investment and Financing (000958.SZ) forecasts a net profit of 3 billion to 3.5 billion CNY, a significant rise of 187.37% to 235.26%[6] - Oriental Securities (600958.SH) expects a net profit of 5.62 billion CNY, up 67.8% year-on-year[9] Industry Trends - AI and high-end manufacturing are driving growth, with companies like Shenzhen South Circuit and Huadian Electric benefiting from AI computing upgrades[47] - Resource prices are showing differentiation, with gold, tungsten, and lithium companies like Zhongjin Gold and Xiamen Tungsten experiencing performance recovery due to strategic resource demand[48] - The financial sector is witnessing a dual trend of stability and transformation, as seen in Oriental Securities and Guotai Junan's performance amid market activity[49] - The recovery in consumer and service industries is highlighted by Wanda Film's return to profitability, indicating a rebound in content and experiential consumption[50] - The pharmaceutical sector is experiencing significant differentiation, with companies like Chengdu Xian Dao achieving high growth through innovation, while others like Bichang Pharmaceutical face competitive pressures[51]

Core Viewpoint - Emei Mountain A is experiencing a recovery in visitor traffic, supported by shareholder rewards during the off-peak season, with expectations for improved capacity [1] Group 1: Visitor Traffic and Shareholder Rewards - The scenic area received 126,166 visitors during the three days of New Year's Day (January 1-3, 2026), with ticket sales of 83,391 and complimentary tickets of 42,775, representing a year-on-year increase of 20.88% compared to the same period in 2024 [1] - A shareholder reward program running from December 1, 2025, to January 31, 2026 (excluding statutory holidays) offers discounts on tickets, cable cars, hotels, and hot springs, which is expected to boost visitor traffic in December and January during non-holiday periods [1] Group 2: Capacity and Financial Performance - Improvements in transportation and capacity are anticipated, which is expected to elevate long-term visitor traffic [1] - The company continues to provide cash dividends to shareholders, reflecting strong cash flow quality and a commitment to shareholder returns, which also enhances capital efficiency and investor return certainty, providing some support for valuation [1] Group 3: Earnings Forecast and Valuation - Due to weak revenue in 2025, adjustments have been made to the EPS forecasts for 2025-2027 to 0.45, 0.54, and 0.61 yuan, respectively, down from previous estimates of 0.63 and 0.69 yuan for 2025-2026 [1] - Based on comparable companies, the target price for 2026 is set at 17.28 yuan, applying a 32 times PE ratio, while maintaining a "buy" rating [1]

Core Viewpoint - Emei Mountain A is experiencing a recovery in visitor traffic, supported by shareholder rewards during the off-peak season, with expectations for improved capacity [1] Group 1: Visitor Traffic and Shareholder Rewards - During the New Year holiday from January 1 to January 3, 2026, the scenic area received 126,166 visitors, a 20.88% increase compared to the same period in 2024 [1] - Shareholder reward activities from December 1, 2025, to January 31, 2026, excluding statutory holidays, are expected to boost visitor traffic in December and January during non-holiday periods [1] Group 2: Capacity and Long-term Outlook - Improvements in transportation and capacity are anticipated, which will likely enhance long-term visitor traffic [1] - The company continues to provide cash dividends to shareholders, reflecting strong cash flow quality and a commitment to shareholder returns, which also aids in improving capital efficiency and investor return certainty [1] Group 3: Financial Forecast and Valuation - Due to weak revenue in 2025, the company has adjusted its EPS forecasts for 2025-2027 to 0.45, 0.54, and 0.61 yuan, down from previous estimates of 0.63 and 0.69 yuan for 2025-2026 [1] - Based on comparable companies, the target price for 2026 is set at 17.28 yuan, applying a 32x PE ratio, while maintaining a "buy" rating [1]

Group 1 - The core focus of the 2026 JPM Conference is on the strategic importance of IO (Immuno-Oncology) and ADC (Antibody-Drug Conjugates) in the oncology sector, with a significant emphasis on combination therapies [1] - The conference, held from January 12 to 15, 2026, in San Francisco, is recognized as a key event for insights into new drug development trends, capital flows, and business development collaborations in the healthcare industry [1] - Major multinational corporations (MNCs) are prioritizing second-generation IO and ADC, with a notable contribution from domestic innovations, particularly the introduction of sac-TMT by Merck as a focal point in oncology development [2] Group 2 - The exploration of combination therapies involving IO and ADC is accelerating, with multiple clinical trials underway, including 16 Phase III trials for sac-TMT and 4 Phase III trials for PD-(L)1/VEGF dual antibodies by Pfizer [2] - The year 2026 is identified as a pivotal year for the combination of IO and ADC, with expectations for increased demand for ADCs as they gain a core position in current cancer treatments [3] - Key players in the ADC market include companies such as Kangfang Biopharma, Sanofi, Rongchang Biopharma, and others, indicating a competitive landscape for ADC development [3]

资产配置 | 定期报告 研究结论 报告发布日期 2026 年 01 月 28 日 | 郑月灵 | 执业证书编号：S0860525120003 | zhengyueling@orientsec.com.cn | | --- | --- | --- | | 021-63326320 | | | | 周仕盈 | 执业证书编号：S0860125060012 | zhoushiying@orientsec.com.cn | | 021-63326320 | | | | 美/日风险评价上升，贵金属及低风险特征 | 2026-01-26 | | --- | --- | | 权益占优：20260126 多资产配置周报 | | | CTA 策略仍强，指增和中性策略回暖： | 2026-01-22 | | 20260119 多策略及理财配置周报 | | | 风偏继续向中间集中：20260119 多资产配 | 2026-01-20 | | 置周报 | | | 以对冲配置思路应对美股/黄金"畏高" | 2026-01-19 | | 国内风险评价稳步下行，A 股/商品占优： | 2026-01-13 | | 20260112 多资产配 ...

Group 1 - Heng Rui Medicine's HRS-5346 tablets have been included in the list of breakthrough therapeutic varieties by the National Medical Products Administration, with a total R&D investment of approximately 76.3 million yuan [30][30] - Yuguang Jin Lead announced a significant short-term stock price increase of 45.01% over five consecutive trading days, raising concerns about the uncertainty of future silver prices [31] - Dongcai Technology's actual controller and vice chairman has been detained and investigated, but the company states that this will not significantly impact its normal operations [32] Group 2 - Aisen Co. plans to invest 2 billion yuan to establish an integrated circuit materials manufacturing base in East China, with the first phase expected to be operational by 2028 [33] - Jingpin Special Equipment has been banned from participating in procurement activities for the armed police force for three years, which will have a limited impact on its overall revenue [34] - Nanhua Futures' overseas subsidiary has obtained membership approval for the Nodal Exchange, allowing it to trade and clear related products [35] Group 3 - Zhong Rare Earth expects a net profit of 100 million to 130 million yuan in 2025, reversing a loss of 299 million yuan in the previous year due to market recovery and operational improvements [38] - Deep South Circuit anticipates a net profit increase of 68% to 78% in 2025, driven by growth in AI computing power and storage market demand [39] - Hai Xin Energy Science and Technology expects a net loss of 450 million to 640 million yuan in 2025, although this is an improvement from a loss of 954 million yuan the previous year [40] Group 4 - Nanya New Materials forecasts a net profit increase of 337% to 417% in 2025, attributed to the recovery in the copper-clad laminate industry [41] - CanSino Biologics expects a net profit of 24.5 million to 29 million yuan in 2025, driven by the growth of its quadrivalent meningococcal vaccine [42] - Zhiguang Electric anticipates a net profit of 110 million to 160 million yuan in 2025, reversing a loss of 326 million yuan due to rapid growth in its energy storage business [43] Group 5 - Dongfang Securities expects a net profit increase of 67.8% in 2025, supported by growth in its core investment banking and wealth management businesses [44] - King Long Motors forecasts a net profit of approximately 463.26 million yuan in 2025, reflecting a 193.68% increase due to steady growth in overseas markets [45] - Zhenray Technology expects a net profit increase of 529.64% to 642.26% in 2025, driven by demand in special integrated circuits and satellite communication markets [46] Group 6 - Yongding Co. anticipates a net profit of 200 million to 300 million yuan in 2025, representing an increase of 225.66% to 388.48% due to investment income from its joint ventures [47] - Xiamen Tungsten's preliminary report indicates a net profit of 2.311 billion yuan in 2025, a 35.08% increase driven by rising prices of tungsten and rare earth materials [48] - Guodun Quantum expects to achieve a net profit of around 5 million yuan in 2025, reversing a loss from the previous year due to growth in the quantum computing sector [49] Group 7 - Shijia Photon anticipates a net profit of approximately 342 million yuan in 2025, reflecting a growth of around 426% due to increased orders in optical chips and cables [50] - Ningbo Fubang expects a net profit of 50 million to 70 million yuan in 2025, with a significant increase of 3099.59% to 4379.43% driven by rising silver prices and non-recurring gains [51] - Huasheng Lithium Battery plans to adjust its share repurchase price limit from 32 yuan to 150 yuan per share, reflecting confidence in its future development [52]